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Telomere positioning effectTelomere length maintenance is critical for organisms' long-term survival and cancer cell proliferation.
Telomeres are kept within species-speciﬁc length ranges by the interplay between telomerase activity and
telomeric chromatin organization. In this paper, we exploited telomerase immortalized human ﬁbroblasts
(cen3tel) that gradually underwent neoplastic transformation during culture propagation to study telomere
composition and length regulation during the transformation process. Just after telomerase catalytic subunit
(hTERT) expression, cen3tel telomeres shortened despite the presence of telomerase activity. At a later stage
and concomitantly with transformation, cells started elongating telomeres, which reached a mean length
greater than 100 kb in about 900 population doublings. Super-telomeres were stable and compatible with
cell growth and tumorigenesis. Telomere extension was associated with increasing levels of telomerase
activity that were linked to the deregulation of endogenous telomerase RNA (hTERC) and exogenous telome-
rase reverse transcriptase (hTERT) expression. Notably, the increase in hTERC levels paralleled the increase in
telomerase activity, suggesting that this subunit plays a role in regulating enzyme activity. Telomeres ranging
in length between 10 and more than 100 kb were maintained in an extendible state although TRF1 and TRF2
binding increased with telomere length. Super-telomeres neither inﬂuenced subtelomeric region global
methylation nor the expression of the subtelomeric gene FRG1, attesting the lack of a clear-cut relationship
between telomere length, subtelomeric DNA methylation and expression in human cells. The cellular levels
of the telomeric proteins hTERT, TRF1, TRF2 and Hsp90 rose with transformation and were independent of
telomere length, pointing to a role of these proteins in tumorigenesis.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Telomeres are specialized nucleo-protein structures that protect
human chromosome ends from nucleolytic digestion and end-
to-end fusions, thus being essential for chromosome stability [1].
Human telomeric DNA is composed of tandem repetitions of the
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rights reserved.where it forms a 100–250 nucleotide long single strand overhang [2].
Because the extension of the repetitions varies from chromosome to
chromosome and from cell to cell, telomeric DNA length is heteroge-
neous both within cells and among chromosomes of a single cell, but
it is generally maintained within a species-speciﬁc range [3]. In
human embryonic cells, for example, the average telomere length is
around 15 kb; in contrast, in mice, telomeres can extend over 50 kb.
Thus, mechanisms exist that restrain telomere length within a deﬁ-
nite extension range.
Telomeres are associated with several proteins, which play an
essential role in telomere maintenance. A six subunit complex
(TRF1, TRF2, RAP1, TIN2, TPP1, POT1), named shelterin [4], speciﬁcally
binds to telomeres and controls telomere stability and length. TRF1
and TRF2 act as in cis negative regulators of telomere elongation
[5–7]. Evidence has been reported that TRF1 controls telomerase-
mediated telomere lengthening through its interaction with POT1,
which binds the telomeric single strand overhang and transduces
TRF1 signals to telomerase, the enzyme deputed to telomere elonga-
tion [8].
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which is due to the unidirectional and primer-dependent DNA poly-
merase synthetic activity. Telomerase is a ribonuclear-protein complex
that elongates the 3′ telomeric ends through a reverse-transcription
reaction, using the RNA moiety (TERC) as template and the catalytic
subunit (TERT) as enzymatic activity [9]. In human cells, together with
TERC and TERT, the regulatory protein dyskerin is required for the for-
mation of a catalytically active telomerase [10] and other proteins par-
ticipate in telomerase biogenesis and regulation. hTERT (human TERT)
expression is tightly regulated during development and its expression
correlates with the presence of telomerase activity; in contrast, hTERC
(human TERC) is constitutively expressed, even when telomerase is
absent. hTERT is expressed at very low levels in most adult somatic
cells [11], while is present in stem cells, germ-line and embryonic
cells. In somatic cells, the low telomerase activity is not sufﬁcient to
maintain telomeres, which shorten at each cell division. When their
length falls below a threshold level, telomeres trigger cellular senes-
cence [12]. Senescent cells remain metabolically active even for years,
but are unable to divide, because short telomeres are recognized as
DNA double strand breaks and activate the DNA damage response
that arrest cells' proliferation [13]. Thus, telomere shortening has been
considered as a “mitotic clock” [14].
In contrast to normal somatic cells, telomerase is active in the vast
majority of tumors (about 85%), in agreement with the requirement
of functional telomeres for an indeﬁnite cellular proliferation [15].
The necessity of preserving functional telomeres in tumor cells is con-
ﬁrmed by the observation that tumor cells lacking telomerase activity
maintain telomeres through a recombination based mechanism known
as alternative lengthening of telomeres (ALT) [16]. Characteristics of
cells adopting this mechanism are a high frequency of sister chromatid
exchanges between telomeres, leading to telomeres highly heteroge-
neous in length, extrachromosomal telomeric DNA circles and PML
(Promyelocytic Leukemia) nuclear bodies containing telomeric chro-
matin (ALT PML bodies) [17].
In several somatic cells, ectopic hTERT expression is sufﬁcient to
induce telomerase activity, allows overcoming cellular senescence
and leads to cellular immortalization [18,19]. In different hTERT
immortalized cell lines, telomeres can reach different extensions
and telomerase activity levels, as well as hTERT and hTERC expres-
sion, play a role in the determination of their length [20,21]. Very
long telomeres, longer than 50 kb, were found in different cell types
in which both hTERT and hTERC were ectopically expressed; these
high levels of telomere elongation correlated with high degrees of
telomerase activity [22,23].
By ectopic hTERT expression, we have obtained a human ﬁbroblast
cell line (named cen3tel) that has become immortal and has under-
gone neoplastic transformation during in vitro propagation [24–27].
The acquisition of the neoplastic phenotype was a gradual phenome-
non; in fact, initially cells maintained a phenotype similar to that of
parental ﬁbroblasts (represented in this work by cells around popula-
tion doubling, PD, 30), then (around PD 100) became able to grow in
the absence of solid support, a feature typical of the initial phases of
transformation [25]. Subsequently (around PD 160), cen3tel cells
acquired the capacity to induce tumors in about one month when
injected subcutaneously into immunocompromised mice and, upon
further propagation in culture, they increased their aggressiveness,
forming tumors with shorter latencies (~8 days around PD 600 and
~2 days around PD 1000). Moreover, cells around PD 1000 were
also able to induce lung metastases when injected into the tail vein of
nude mice [24,27]. In cen3tel cells, anchorage independent growth
was associated with downregulation of the CDKN2A locus, while neo-
plastic transformationwith p53 inactivation and c-MYC overexpression
[27].
We also found that, after the transformation process, cen3tel cells
lost the ability to regulate telomere length at a steady state level and
reached an average telomere extension greater than 100 kb. In thiswork, we investigated the mechanisms leading to the loss of telomere
length homeostasis.
2. Materials and method
2.1. Cells and cell culture
Cen3tel cells were obtained from primary cen3 ﬁbroblasts, by infec-
tion with an hTERT-containing retrovirus [25]. MDA-MB-231 (breast
cancer), U373 (glioblastoma), primary cen3 and cen3tel cells were
grown in Dulbecco's modiﬁed Eagle's Medium (DMEM, Euroclone)
supplemented with 10% fetal bovine serum (Lonza), 2 mM glutamine,
and 1% non-essential amino acids (Euroclone), 0.1 mg/ml penicillin
(Euroclone), 100 U/ml streptomycin (Euroclone) at 37 °C in an atmo-
sphere containing 5% CO2. Cen3tel cells were used at different PDs
comprised between PD 30 and PD 1200. To establish clonal cen3tel pop-
ulations, single cells at PD 262 were seeded at low density (50 cells/
10 cmdiameter dish) and clones derived froma single cell were isolated
and propagated in vitro. PD numbering of the clones was restarted,
counting all the divisions performed by the single cell that generated
the clone.
2.2. Analysis of telomere length and telomerase activity
Telomere length was determined by analyzing the mean length of
the terminal restriction fragments (TRFs) by Southern blotting. For
the analysis of TRFs below 20 kb, DNA samples were processed and
hybridized as described in Mondello et al. [25]. For the analysis of
longer telomeres, DNA samples were prepared from 106 cells embed-
ded in 2% InCert Agarose (Cambrex) and sequentially digested with
20 U of AfaI ﬁrst and HinfI then. DNA fragments were separated
through a 1% agarose gel in 0.5× TBE, using the CHEF-DR®II Pulsed
Field Electrophoresis System (Bio-Rad). Separation was performed
at 14 °C either for 13 h at 6 V/cm at a switch time of 0.5–2 s or for
16 h at 6 V/cm at a switch time of 5–20 s. Southern blot was then
carried out as in [25]. The signal intensity along each lane was quan-
tiﬁed by the Image-Quant software and the data were used to deter-
mine the mean length of TRFs as described by Harley et al. [28].
Telomeres were visualized on mitotic chromosomes by performing
ﬂuorescence in situ hybridization (FISH) on metaphase spreads using a
FITC-labeled (ccctaa)3 peptide nucleic acid probe (PNA, PerSeptive
Biosystems) following the procedure set up by Lansdorp et al. [29],
with minor modiﬁcations. Cells were denaturated in situ at 70 °C for
2 min in 70% formamide, 1% Blocking Reagent (Roche), 10 mM Tris–
HCl pH 7.0, 2 μg/ml PNA, and then hybridized at room temperature
for 2 h. Washes were performed at room temperature in 70% formam-
ide in 10 mM Tris–HCl pH 7.2, and then in 150 mM NaCl, 50 mM Tris–
HCl pH 7.5, 0.05% Tween 20. Chromosomes were counter-stained with
0.2 μg/ml DAPI (4′,6-diamidino-2-phenylindole) in PBS for 10 min.
Slides were analyzed using an optical microscope Olympus IX71
equipped with a 100× objective. Images were acquired with a digital
camera Cool SNAPES (Photometrics) using the MetaMorph software.
Figures were assembled using Adobe Photoshop and Adobe Illustrator.
Telomerase activity was analyzed using the TRAPeze kit (Chemicon)
according to the manufacturer's instructions. DNA fragments were
separated on polyacrylamide gels, which were stained for 15 min
with 1× SYBR Gold Nucleic Acid Gel Stain (Molecular Probes, Life
Technologies) in 0.5× TBE.
2.3. RNA extraction, reverse transcription-PCR (RT-PCR) and real-time
RT-PCR
Total RNA was extracted from actively dividing cells using the
Trizol reagent (Life Technologies). For RT-PCR, cDNA was generated
from 1 μg of RNA using the QuantiTec Reverse Transcription Kit
(Qiagen), following the manufacturer's instructions. cDNA (2 μl
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To detect the expression of endogenous hTERT, the primer RA58
(5′-ggctgaagtgtcacag) and the primer hTERT3′UTR (5′-ggccgagagcag
acaccagcagcc) in the 3′ untranslated region [19] were used; PCR
was carried out for 40 cycles with an annealing temperature (Ta)
of 64 °C. As primers within the hTERT cDNA, the primers LT5
(5′-cggaagagtgtctggagcaa) and LT6 (5′-ggatgaagcggagtctgga) [20]
were used; PCR was carried out for 25 cycles with a Ta of 56 °C. For
FRG1 expression analysis the following primers were used: 1F
(5′-tctacagagacgtaggctgtca) and 9R (5′-ataaggcagaaacaaaaatccc); the
primers for GAPDH were: forward 5′-accacagtccatgccatcac and re-
verse 5′-tccaccaccctgttgctgta. Semi-quantitative PCR was carried out
for a number of cycles in the range of reactions' exponential phase
(28 cycles with a Ta of 58 °C for FRG1 and for 25 cycles with a Ta of
60 °C, for GAPDH). PCR products were analyzed on a 1.5% agarose
gel stained with 1× SYBR Gold (Life Technologies) in 1× TBE as in
the TRAP assay (see above). The primers for Rpl13a were acquired
by Qiagen; PCR was carried out for 25 cycles with a Ta of 60 °C.
For the real-time RT-PCR experiments, the PD of cen3tel cells is
not speciﬁed because more than one RNA sample was prepared and
used for cen3tel cells around PD 30, 100, 160, 600 and 1000. Gene
expression was quantiﬁed by SYBR Green chemistry using the
QuantiTect SYBR Green Kit (Qiagen). For TERC, the primers TERC for-
ward (5′-tctaaccctaactgagaagg) and TERC reverse (5′-gtttgctctagaat
gaacgg) [30] were used. For TRF1, TRF2 and GusB dedicated sets of
commercial primers (Qiagen) were used. Reactions were run in trip-
licate for each experimental point and each experiment was repeated
at least twice. Real-time PCR was done on the Light Cycler 480
(Roche), using 96-well reaction plates. Raw data were normalized
using the results obtained with the GusB housekeeping gene.
2.4. Western blotting
Whole-cell lysates for Western blot analysis were prepared lysing
the cells in coimmunoprecipitation buffer (10 mM Tris–HCl (pH 7.6),
0.5% NP40, 140 mMNaCl, 5 mM EDTA (pH 8.0), 1× protease inhibitor
cocktail (Sigma-Aldrich) and 2 mM NaVO4). For each sample, 50 μg
of protein extract were loaded onto the gels. The following antibodies
were used: anti-hTERT (95110, DIESSE); anti-Hsp90 (N-17, Santacruz);
anti-TRF1 (ab [57-6], Abcam); anti-TRF2 (clone 4A794, Upstate);
anti-γ-tubulin (clone GTU-88, Sigma). All primary antibodies were
probed by a secondary horseradish peroxidase-conjugated antibody
(Jackson Laboratories). Chemiluminescent assay was used for detection
(Super SignalWest Pico, Pierce orWestern C, Bio-Rad). The intensity of
the bandswas quantiﬁed using Image-Quant, corrected for the intensity
of the bands in the loading control and then normalized either relatively
to primary cen3 ﬁbroblasts or to cen3tel cells at the earliest passage.
2.5. Chromatin immunoprecipitation (ChIP)
For ChIPs, cells were ﬁxed for 10 min at room temperature adding
formaldehyde in culture medium at a ﬁnal concentration of 0.75%.
Then, cells were lysed in 140 mM NaCl, 50 mM HEPES-KOH pH 7.5,
1 mM EDTA pH 8.0, 1% Triton X-100, 0.1% SDS, 0.1% Sodium
deoxycholate and 1× protease inhibitor cocktail (Roche) at a density
of 1.3 × 107/ml. Lysates were sonicated to obtain chromatin frag-
ments of 0.5–1 kb. 20–25 μg of chromatin of each sample were diluted
in a ﬁnal volume of 2 ml in binding buffer (150 mMNaCl, 20 mM Tris–
HCl pH 8.0, 2 mM EDTA pH 8.0, 1% Triton X-100, 1× protease inhibitor
cocktail) and pre-cleared with 20 μl of Protein A/G PLUS-Agarose
beads (Santa Cruz Biotechnology) overnight at 4 °C. Samples were
centrifuged and supernatants were incubated for 5 h at 4 °C with 4 μg
of anti-TRF1 (N19-R, Santa Cruz Biotechnology) or anti-TRF2 (clone
4A794, Upstate) antibody and then supplementedwith 80 μl of blocked
beads and incubated over night at 4 °C. Immunoprecipitated pellets
were washed four times with binding buffer containing 150 mM NaClin the ﬁrst threewashes and 500 mMNaCl in the ﬁnal wash. Chromatin
was eluted from the beads with 100 mMNaHCO3, 1% SDS for 15 min at
room temperature. After the addition of 0.5 mg/ml RNAse A, crosslinks
were reversed overnight at 65 °C. In parallel, for each sample, an
amount of chromatin equal to that used for the ChIP assays was
processed to remove crosslinks and give rise to the total DNA samples.
After this step, DNA was puriﬁed with Qiaquick PCR Puriﬁcation Kit
(Qiagen) and eluted with 50 μl water. Eluates were denatured and
slot blotted onto Nytran Nylon membranes (Schleicher & Schuell);
80% of each immunoprecipitated sample was loaded for the detection
of telomeric sequences and 20% for Alu sequences; 1% and 20% of each
total DNA sample were loaded in parallel.
Membrane hybridization was performed overnight at 44 °C with a
5′ 32P- or digoxigenin (Dig)-labeled TELO probe (5′-(ccctaa)5) or a
Dig-labeled probe for the consensus sequence of the ALU-J subfamily
(5′-gtgatccgcccgcctcggcctcccaaagtg, ALU probe). Membranes hybrid-
ized with the 32P-labeled probes were exposed overnight to
PhosphorImager screens; membranes hybridized with the Dig-
labeled probe were incubated with an anti-Dig-HRP conjugated anti-
body (Jackson ImmunoResearch) and the signal was revealed using
SuperSignal West Femto (Pierce). Quantiﬁcation of the percentage
of precipitated DNA was done with the QuantityOne software
(Bio-Rad). The percentage of telomeric DNA immunoprecipitated in
each cen3tel sample was calculated relatively to the telomeric signal
in the corresponding total DNA. Therefore, the calculated ChIP yield
takes into account changes in telomere length. ChIP experiments
were repeated four times with the anti-TRF1 antibody and twice
with the anti-TRF2 one.
2.6. DNA methylation of subtelomeric loci
Methylated DNA immunoprecipitation was performed as previously
described [31,32]. Genomic DNA was isolated from cen3tel cells using
DNeasy Blood and Tissue kit (Qiagen). 4 μg of genomic DNA was
fragmented by sonication to sizes ranging from 200 bp to 1000 bp.
Methylated DNA fragments were immunoprecipitated with an
anti-5m-cytosine rabbit polyclonal antibody (MegabaseResearch
#CP51000) or with rabbit IgG as control. Isolated DNA was subject to
real-time PCR analysis. Primers sets for proximal subtelomeric region
from chromosome 2 TRB1 repeats were 5′-tggaacctcaataatccgaaa and
5′-gctggacaccactgtaagca. Primer sets for the D4Z4 megasatellite found
at 4q, 10q and 18p subtelomeric regions were 5′-ctcagcgaggaagaataccg
and 5′-accgggcctagacctagaag. GAPDH promoter region was used as
negative control, and primer sets were 5′-cgtgcccagttgaaccag and
5′-cgcccgtaaaaccgctagta.
3. Results
3.1. Telomere length dynamics during cen3tel cell lifespan
Infection of primary cen3 ﬁbroblasts with a retrovirus carrying the
hTERT cDNA restored telomerase activity and allowed cells to become
immortal, giving rise to the cen3tel cell population. We studied
telomere length dynamics during culture propagation of the immor-
talized cells, between PD 30 and PD 1200, by analyzing the distribu-
tion of the terminal restriction fragments (TRFs) by Southern
blotting with a probe for the telomeric repeats. Initially, DNA samples
prepared from cells between PD 30 and PD 400 were analyzed after
restriction enzyme digestion and separation by conventional gel elec-
trophoresis (Fig. 1a). At these stages, we observed a peculiar telomere
dynamics since telomeres kept on shortening up to about PD 100, the
lowest mean TRF length, 5.7 kb, was found in cells at PD 112 (Fig. 1a
lane 4), and then started to be elongated (see also [25]). Because in
cells at the most advanced PDs, TRFs became too long to be resolved
by conventional agarose gel electrophoresis, telomeric fragments
obtained from cells from PD 167 up to PD 1200 were separated by
Fig. 1. Telomere length in cen3tel cells and clonal populations at different propagation stages. (a–d) Southern blot analysis of TRF distribution using a telomeric radioactive probe.
Restriction enzyme digested DNA samples prepared from cen3 primary ﬁbroblasts (a, lane1), cen3tel cells at different PDs (a–c) or cen3tel clonal populations (d) were either sep-
arated on an agarose gel through conventional electrophoresis (a, d) or through pulse ﬁeld gel electrophoresis (b) for 13 h at 6 V/cm at a switch time of 0.5–2 s or (c) for 16 h at
6 V/cm at a switch time of 5–20 s. Clonal populations were derived from cen3tel cells at PD 262 and were analyzed at different PDs together with their parental cells both at the
stage at which they were seeded for clone isolation (panel d, lane 1) and at a later stage (panel d, lanes 2 and 3). PD numbering of the clones was restarted from the seeding of the
cells (see Materials and methods). The size (kb) and the position of the molecular weight markers are indicated on the left. (e–f) FISH analysis of telomeres in cen3tel cells at PD 338
(e) and 775 (f) using a ﬂuoresceine-labeled telomeric PNA probe (bright spots). Metaphases were counterstained with DAPI. Image acquisition was performed with the same ex-
posure time to allow comparison of the hybridization signal intensity.
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and DNA restriction enzyme digestions were performed in agarose
plugs as described in Materials and methods. As shown in Fig. 1b
and c, telomere length continuously increased up to PD 1000 and no
further telomere lengthening was detected in cells between PDs
1000 and 1200 (Fig. 1c, lanes 2–6). The mean TRF lengths were com-
prised between about 11 kb in cells at PD 167 and more than 100 kb
in cells at PDs 1000–1200, with mean lengths around 14, 26, 42, 59
and 80 kb in cells at PDs 241, 334, 407, 505 and 671, respectively.
To determine whether telomere elongation was a property of all,
or at least most, cen3tel cells and was not due to the gradual selection
of cells with long telomeres, we isolated 4 clones from cen3tel cells at
PD 262 and analyzed telomere length in each of them and in parental
cells propagated in parallel at successive PDs. Telomere length in-
creased with propagation in parental cells (Fig. 1d, lanes 1–3), as well
as in all the 4 clones (Fig. 1d, lanes 4–13).
Taken together, these results indicate that cen3tel cells lost the
ability to refrain telomere elongation, which reached values not yet
described in human cells.
We then performed ﬂuorescence in situ hybridization on meta-
phase chromosomes from cen3tel cells at different PDs using a ﬂuo-
rescent PNA probe hybridizing with telomeric DNA repeats. Visual
analysis revealed that telomeric signal intensities in cells at different
PDs displayed the same increasing trend as the mean TRF length (in
Fig. 1e and f, examples of mitoses hybridized with the telomericprobe from cells at PD 338 and PD 755, respectively, are shown). In
addition, hybridization signals were homogeneous among telomeres
of the same mitosis. This result, together with the narrow TRF
distribution observed in cen3tel cells by gel analysis, indicates that
all telomeres are highly elongated during cen3tel cell propagation.
Moreover, it suggests that telomere lengthening is not due to ALT
activation, which is characterized by a marked heterogeneity in telo-
mere length. The lack of ALT activation was also supported by the
absence of ALT PML bodies (data not shown).
3.2. Telomerase activity, telomerase subunit and telomerase regulatory
protein expression in cen3tel cells at different PDs
We determined telomerase activity using the TRAP assay in
cen3tel cells at different PDs. As shown in Fig. 2a, telomerase activity
increased in cells at successive PDs up to around PD 600 (about 6×
compared to cen3tel PD 34) and then reached a plateau (quantiﬁca-
tion of the intensity of the bands is shown in Fig. S1a). This indicates
that telomere lengthening in cen3tel cells is due to an increase in tel-
omerase activity, which parallels cellular transformation. Telomerase
activity levels in late PD cen3tel cells were higher than in other tumor
cell lines analyzed (e.g. MDA-MB-231, Fig. 2a, lane 14, Fig. S1a).
Because a typical feature of neoplastically transformed cells is the
activation of the hTERT gene, we tested whether endogenous hTERT
had been activated in transformed cen3tel cells, contributing to the
Fig. 2. Telomerase activity and telomerase subunit expression in cen3 primary ﬁbroblasts and cen3tel cells at different propagation stage. (a) Telomerase activity was determined by
TRAP assay, the gel was stained using SYBR Gold. IC: internal control; MDA: protein extracts from MDA-MB-231 breast cancer cells used as positive control; above each lane, the
amount of protein extract (ng) used is indicated. (b) RT-PCR analysis of endogenous and exogenous hTERT expression. To analyze endogenous hTERT expression, the 3′ primer was
located in the 3′ untranslated region (hTERT UTR-primer) that is not present in the transfected hTERT cDNA. Exogenous hTERT was detected with primer internal to the cDNA. The
size (bp) of the molecular weight markers is indicated on the left; RPL13a was used as internal control; MDA-MB-231 (MDA) and U373 cells were used as positive control for
endogenous hTERT expression. (c) Western blot analysis of hTERT and Hsp90 expression. γ-Tubulin was used as loading control. (d) Real-time RT-PCR analysis of hTERC expression
levels. hTERC expression is indicated relatively to cen3 primary ﬁbroblasts. Error bars represent standard deviations.
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using a primer within the coding region and another one in the 3′
untranslated region, which is not present in the hTERT cDNA used
for immortalization. As shown in Fig. 2b (upper panel), no expression
of endogenous hTERT could be detected in cen3tel cells at different
stages of propagation, even after 40 cycles of PCR. In contrast, RT-PCR
performed using primers internal to the hTERT cDNA gave the
expected ampliﬁcation products, the intensity of the ampliﬁcation
bands was similar in all the cen3tel samples and higher than in the
tumor cell lines MDA-MB-231 and U373 (Fig. 2b mid panel lanes 2–7
vs. lanes 8, 9).
In the attempt to understand the molecular mechanisms leading
to the increase in telomerase activity, we analyzed the expression
levels of the hTERT protein and hTERC in cen3tel cells at different
PDs, as well as of proteins which regulate telomerase assembly and
function, such as Hsp90, its co-chaperon molecule p23, and different
isoforms of the protein kinase C (PKC α, βI, βII, δ, ε).
Western blot analysis using an antibody against hTERT (Fig. 2c,
upper panel), revealed, as expected, the lack of signal in primaryﬁbroblasts; in cen3tel cells, hTERT expression levels increased (about
6×) in cells at PD 102 compared to cells at PD 34, remained roughly
constant up to PD 624 and then decreased in cells at PD 1012 (quantiﬁ-
cation of the band intensity is shown in Fig. S1b).
A similar expression modulation was found for Hsp90. In cells at
PD 102, Hsp90 expression increased (about 2× compared to parental
cen3 ﬁbroblasts, augmented further at PD 190 (about 3×) and then
remained stable at the subsequent PDs (Fig. 2c, lower panel and
Fig. S1c). Thus, both Hsp90 and hTERT levels increased when telo-
meres started to be elongated, but did not show a continuous increase
paralleling the rise in telomere length and telomerase activity.
Interestingly, the boost in the expression of both proteins occurred
together with the initial phases of transformation.
Western blot analysis did not show changes in the expression of
p23 and the different PKC isoforms analyzed during cen3tel cell prop-
agation (data not shown).
hTERC expression in cen3tel cells at different PDs showed an up
and down trend (Fig. 2d). In fact, in cen3tel cells around PD 30, it
was higher (3.7×) than in parental cells, then it went back to values
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increased again in cells from PD 160 up to PD 1000 (from about 2×
to 4.6×).
3.3. TRF1 and TRF2 expression and binding to telomeric DNA in cen3tel
cells with increasing telomere length
The above results show a continuous increase in telomere length
in cen3tel cells from PD 100 up to PD 1000 with the achievement
of a length not yet described in human cells. To test whether the
telomeric proteins TRF1 and TRF2, key in cis regulators of telomere
length, played a role in the unrestrained telomere elongation, we
analyzed their binding to telomeres in cen3tel cells at subsequent PDs
by chromatin immunoprecipitation assays (Fig. 3a–d).
To quantify the proteins bound to the telomeric DNA, chromatinwas
immunoprecipitated using an anti-TRF1 or anti-TRF2 antibody, after in
vivo cross-linking between DNA and associated proteins. Cross-linking
was then reversed and the DNA co-immunoprecipitated with the pro-
teins was quantiﬁed by slot-blot hybridization using a probe for the
TTAGGG telomeric repeats (Fig. 3a). In each cell sample, the hybridiza-
tion signal of the immunoprecipitated telomeric DNA was quantiﬁed
relatively to the telomeric hybridization signal in the corresponding
total DNA, to take into account telomere length, which increased with
PDs. The percentage of telomeric DNA immunoprecipitated by TRF1
was around 10% in all the cell samples (10%, 8%, 11% and 10% in cen3tel
cells at PDs 168, 333, 652 and 1109, respectively). This result indicates
that TRF1 binds all along telomeres ranging in length from aboutFig. 3. TRF1 and TRF2 telomere binding and expression. (a) ChIP of telomeric DNA by anti
amount of total DNA blotted, the antibodies used for IP and the hybridization probes (TTA
revealed using a 32P-labeled TTAGGG probe, the other membranes were hybridized with
chemiluminescence. (b) Western blot analysis of TRF1 and TRF2 expression in cen3 primary
c) Real time RT-PCR analysis of TRF1 and TRF2 expression in cen3tel cells at different propa
ﬁbroblasts. Error bars represent standard deviations. d) In the plot, for cen3tel cells at diffe
relatively to cen3 primary ﬁbroblasts (as shown in Fig. S1d,e) and the corresponding rela
the mean TRF length in primary ﬁbroblasts) is shown.11 kb (in cells around PD 160) to more than 100 kb (in cells around
PD 1000), suggesting that telomere lengthening is not due to a reduced
occupancy of TRF1 at telomeres.
A similar conclusion could be drawn for TRF2 binding to telomeres.
The efﬁciency of telomeric chromatin immunoprecipitation with the
anti-TRF2 antibody was lower than with the anti-TRF1 antibody
(Fig. 3a), but the percentage of telomeric DNA immunoprecipitated
was similar in the different samples and was around 1%.
We then analyzed TRF1 and TRF2 total cellular levels in cen3tel
cells at different PDs by western blot. Compared to parental ﬁbro-
blasts and cen3tel cells around PD 30, the expression of both proteins
increased in cen3tel cells at the earliest phases of transformation
(cen3tel PD 107), showed a further increase in cells around PD 160
and then remained fairly stable (Fig. 3b and Fig. S1d,e). The increased
protein levels were not determined by a corresponding increase in
the mRNA levels, as demonstrated in quantitative RT-PCR experi-
ments (Fig. 3c). Considering the ratio between TRF1 and TRF2 abun-
dance and telomere length in cells at different PDs (Fig. 3d), it
appears that, at the initial phases of transformation (PD 100 and
160), both proteins are in vast excess with respect to telomere length.
3.4. Methylation and expression of subtelomeric loci in cen3tel cells with
different telomere length
Since evidence was reported that telomere length could affect
methylation levels of subtelomeric DNA [33], we exploited cen3tel
cells characterized by highly different telomere lengths to test this-TRF1 and anti-TRF2 antibodies in cen3tel cells at different stages of propagation. The
GGG or Alu probes) are indicated at the top. DNA immunoprecipitated by TRF2 was
a Dig-labeled TTAGGG or ALU probe and the hybridization signal was revealed by
and cen3tel cells at different propagation stages. γ-Tubulin was used as loading control.
gation stages. TRF1 and TRF2 expression levels are indicated relatively to cen3 primary
rent PDs, the ratio between the abundance of TRF1 (gray bars) and TRF2 (black bars)
tive telomere length (calculated by dividing the mean TRF length in each sample by
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mean TRF lengths of about 6 kb, 25 kb and greater than 100 kb,
respectively. We analyzed the global level of methylation of tandemly
repetitive DNA (TRB1 and D4Z4) located at several subtelomeric sites
(TRB1: subtelo 2p; D4Z4: subtelo 4q, 10q and 18p) bymethyl-DNA im-
munoprecipitation. DNA samples prepared from cells at the three dif-
ferent stages of propagation were immunoprecipitated with an anti-
methyl-cytosine antibody and the amount of DNA immunoprecipitated
in the different cell samples was quantiﬁed by real-time PCR using
primers speciﬁc for each repetition family. In Fig. 4a and b, the results
of two independent experiments analyzing methylation at the two
loci are shown. Although variability was present among the results of
the two experiments, we did not ﬁnd any relationship between telo-
mere length and the degree of methylation at these loci. In particular,
in cen3tel cells around PD 1000 we did not detect variations in the
subtelomeric region methylation compared to the other cell samples,
despite the exceptional telomere length.
We then analyzed whether telomere length could inﬂuence the
expression of the subtelomeric locus FRG1. FRG1 is located centromeric
to the D4Z4 repeats and is involved in Facioscapulohumeral muscular
dystrophy [34,35]. In order to analyze FRG1 expression, a semi-
quantitative RT-PCR was performed. Quantiﬁcation of FRG1 PCR
products, normalized relatively to GAPDH, did not reveal differences
between the expression of the gene in cen3tel cells around PD 100Fig. 4. Methylation and gene expression in subtelomeric regions of cen3tel cells with
different telomere length. For methylation analysis (a, b) DNA was extracted from
cen3tel cells at different PDs and immunoprecipitated with anti methyl-cytosine
antibodies; the amount of TRB1 (a) and D4Z4 (b) sequences precipitated in the
different cell lines was quantiﬁed by real-time PCR and normalized relatively to GAPDH
promoter sequences. (c) RT-PCR analysis of FRG1 expression in cen3tel cells at PD 108
and 1008. The size (bp) of the molecular weight markers is indicated on the left.and around PD 1000 (Fig. 4c), indicating that very long telomeres do
not impair the expression of this subtelomeric locus.
4. Discussion
Telomere maintenance plays a key role in tumorigenesis, where it
mainly depends on the activation of hTERT expression, followed by
telomerase activity induction. Telomere maintenance and elongation
involve several different factors, such as telomerase activity itself, the
levels of telomerase components, telomerase ancillary proteins, as
well as telomeric proteins. In this work we have investigated telo-
mere dynamics and composition in hTERT immortalized human
ﬁbroblasts that underwent neoplastic transformation, showing that
transformed cells can lose telomere length homeostasis, reaching
telomere length greater than 100 kb, and deregulate the expression
of telomere maintenance factors, both in relationship to telomere
length and neoplastic transformation.
Analyzing telomere length during the life span of the immortal-
ized ﬁbroblasts, we found that telomeres initially shortened reaching
lengths typical of senescent cells, subsequently, started to be elongat-
ed attaining a mean length greater than 100 kb. This average length
was maintained without detectable variations for at least 200 addi-
tional PDs. Telomere lengthening was a property of all or most cells
of the population; in fact, in four out of four clones isolated from
cells around PD 200, telomeres were elongated during in vitro propa-
gation. We did not ﬁnd evidence of ALT mechanism activation and
telomere length was homogenous among chromosome ends within
cells and among cells at the same propagation phase.
To our knowledge, the telomere length observed in the cen3tel
cellular system represents the upper limit of telomere elongation so
far described in human cells. It has been proposed that telomere
lengthening beyond a certain threshold, posing constraints to cellular
proliferation, could trigger telomere trimming, that is a mechanism
for telomere length regulation based on homologous recombination.
This mechanism leads to the excision of telomeric DNA and the for-
mation of circles of double-stranded telomeric DNA (t-circles), thus
limiting telomere length [36]. Telomere trimming has been described
in cells with telomeres shorter than 20 kb. Our results indicate that
cells can cope with telomeres much longer than 20 kb without the
need of activating mechanisms for telomere shortening. The presence
of such super-telomeres did not pose any constraints to cells' survival
and proliferation; we did actually ﬁnd that cell growth increased dur-
ing propagation of cen3tel cells and was the highest in the cells with
the longest telomeres [37]. Moreover, long telomeres were not an ob-
stacle to tumorigenesis, being the cells with the longest telomeres
highly aggressive when injected under the skin of immunocompro-
misedmice and able to metastasize when inoculated into the animals'
tail vein [24].
Exogenous overexpression of both hTERT and hTERC in human
ﬁbroblasts and tumor cell lines was found to lead to higher levels of
telomerase activity and greater telomere lengthening than the ectopic
expression of hTERT alone [22], indicating that both telomerase sub-
units regulate and are limiting for telomerase activity. In our cellular
system,we found that telomere lengtheningwas linked to a progressive
increase in telomerase activity, which reached levels higher than in
tumor cell lines expressing endogenous TERT. Both hTERT and hTERC
expression levels rose during cen3tel cell life span, althoughwith differ-
ent trends. As expected, hTERT was undetectable in primary ﬁbroblasts
and expressed in transduced cells around PD 30, then its levels
increased in cells at the early phases of transformation without further
increase thereafter. Neoplastic transformation was not associated with
reactivation of endogenous hTERT or transcriptional regulation of the
exogenous hTERT cDNA, indicating that high hTERT levels can also be
achieved through post-transcriptional regulation mechanisms.
hTERC was expressed in primary ﬁbroblasts, its levels increased as
soon as hTERT was expressed in the cells, and decreased thereafter, in
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propagation, reaching the highest levels in cells around PD 1000.
Considering the expression of each telomerase subunit and telome-
rase activity in cells at different stages of propagation, we can infer
that the reciprocal levels of both telomerase subunits are important
to determine telomerase activity. In fact, in cen3tel cells around PD
100, the high hTERT expression relatively to cells at the preceding
stage did not lead to an increase in telomerase activity, probably
because of the low hTERC expression. On the other hand, in cen3tel
cells around PD 1000, despite the lower hTERT levels compared to
cells at the previous phase, telomerase activity was not compromised,
probably because of the higher hTERC expression. These results con-
ﬁrm a role of hTERC in limiting or enhancing telomerase activity
and determining telomere length, as previously shown in cellular sys-
tems in which hTERC had been exogenously overexpressed [22,23].
Moreover, they indicate that hTERC expression can spontaneously
undergo deregulation during neoplastic transformation, contributing
to the induction of a highly efﬁcient enzyme.
Evidence has been reported that auxiliary telomerase proteins,
such as different protein kinase C isoforms and the chaperon proteins
p23 and Hsp90, are involved in telomerase activity regulation [38,39]
and are overexpressed in several tumors, thus we analyzed the ex-
pression of these proteins in cen3tel cells at different stages of prop-
agation. We found that PKC isoform and p23 expression levels were
stable during cell propagation, suggesting that these proteins do not
play a role in determining the increase in telomerase activity and
telomere length observed in cen3tel cells. In contrast, we did ﬁnd a
modulation of Hsp90 expression, with increased protein levels in
transformed and tumorigenic cells compared to parental ﬁbroblasts
and early passage cen3tel cells, which could contribute to determine
the high telomerase activity observed in these cells. On the other
hand, the high Hsp90 expression in transformed and tumorigenic
cen3tel cells could also play a role in determining their transformed
phenotype; in fact, Hsp90 is known to be overexpressed in cancer
cells, in which contribute to tumorigenesis protecting different mu-
tated and overexpressed oncoproteins from misfolding and degrada-
tion [40].
TRF1 and TRF2 are well known negative regulators of telomere
length in mammalian cells, being part of a negative feedback loop
that prevents telomere elongation in cis [5–7]: the high number of
bound telomeric proteins on long telomeres would constrain their
lengthening. In cen3tel cells, ChIP experiments showed that the
amount of TRF1 and TRF2 bound to telomeres increased with telo-
mere length, indicating that telomeres can be maintained in an
extendible state over a range of lengths between 10 and 100 kb,
despite TRF1 and TRF2 binding throughout all their length. Although
TRF1 and TRF2 binding to telomeres does not seem to be involved
in telomere length deregulation in cen3tel cells, we cannot exclude
that variations in the expression or binding of proteins interacting
with the telomeric 3′ overhang, such as POT1 and TPP1, could con-
tribute to this phenomenon [4].
As well as hTERT and Hsp90, TRF1 and TRF2 cellular levels in-
creased concomitantly with transformation, probably because of
post-transcriptional regulation mechanisms, since no variations in
the corresponding mRNAs were observed in cells at different PDs.
The vast excess of TRF1 and TRF2 with respect to telomere length in
cells at the initial phases of transformation suggests that these pro-
teins can play a role in the transformation process itself. This is in
agreement with the hypothesis that these proteins play also a role
in tumorigenesis. To this regard, evidence has been reported that
TRF1 and TRF2 expression is increased in different types of human
cancers, such as gastric, hepatocellular and lung carcinomas, as well
as in human breast-tumor derived cell lines [41–44]. Moreover, a
role for TRF2 in tumorigenesis was conﬁrmed by showing increased
carcinogenesis in TRF2 overexpressing mice [45], on the one hand,
and reduced tumorigenicity of malignant cell lines after TRF2inhibition [46], on the other hand. The mechanism by which TRF1
and TRF2 are linked to tumorigenesis is still unknown. Analysis of
TRF2-overexpressing telomerase-deﬁcient mice suggested a role for
TRF2 in telomere shortening and chromosomally instability-driven car-
cinogenesis [47]. However, our results indicate that this cannot be the
only mechanism, given the very long and stable telomeres characteriz-
ing cen3tel cells. The recent observation that TRF1 and TRF2 also bind to
intrachromosomal sequences often located close to genes or within
introns [48] opens up the possibility that these telomeric proteins
participate in carcinogenesis regulating the expression of genes rele-
vant to this process.
Besides telomeric proteins and telomerase activity, epigenetic
modiﬁcations of telomeric and subtelomeric chromatin have been
implicated in telomere maintenance [49]. It has been proposed that
the loss of heterochromatic marks in telomeric and subtelomeric re-
gions leads to telomere elongation. Subtelomeric DNA demethylation
due to the loss of the expression of the maintenance DNA
methyl-transferase 1 in mouse ES cells has been shown to lead to
telomere lengthening, while telomere shortening in telomerase
deﬁcient mouse models has been found to be associated with
subtelomeric DNA demethylation, suggesting that subtelomeric DNA
epigenetic status and telomere length can reciprocally modulate
each other. Contrasting results have been presented concerning the
possible relationship between subtelomeric DNA methylation and
telomere length in cancer cells [50,51]. Moreover, in a recent paper,
Gadalla et al. [52], studying DNA methylation at the D4Z4 subtelomeric
repeat in lymphocytes from a cohort of Dyskeratosis congenita patients
and their mutation negative relatives, found a positive correlation
between methylation levels and telomere length in the patients and a
negative, but no signiﬁcant correlation, in the normal individuals.
In our cellular system, we analyzed global DNA methylation of the
tandemly repeated TRB1 sequence, located at the 2p subtelomere, and
D4Z4 DNA, located at the 4q, 10q and 18p subtelomers, in cen3tel
cells at three different stages of propagation with mean TRF length
around 6, 25 and more than 100 kb, respectively, and we did not ﬁnd
a relationship between telomere length and global DNA methylation
levels. We cannot exclude that telomere length inﬂuences DNAmethyl-
ation at speciﬁc subtelomeric sites; however, our data indicate that
massive telomere elongation in human transformed ﬁbroblasts is not
associated with a massive change in DNA methylation at subtelomeres
and, vice versa, a massive decrease in DNAmethylation at subtelomeres
is not required for telomere elongation. In agreementwith this observa-
tion, we did not observe variations in the expression of the FRG1 gene,
located at 4q [34], in cells around PD 100 and in cells around PD 1000,
which have telomeres shorter than 10 kb and longer than 100 kb,
respectively.5. Conclusions
In conclusion, in this work we have shown that transformed
human ﬁbroblasts can reach a telomere length greater than 100 kb
without any impairment in cellular growth and tumorigenic poten-
tial. The genesis of super-telomeres is associated with an increase in
hTERT and hTERC expression during transformation, which leads to
high levels of telomerase activity. Moreover, our data indicate that
the relative levels of the two telomerase subunits are crucial for the
determination of the enzymatic activity. Although we cannot deﬁne
a causal relationship between cellular transformation and the loss of
telomere length homeostasis, our results show that the initial phases
of transformation coincides with the increase in the expression
of proteins involved in telomere metabolism, such as TRF1, TRF2,
Hsp90 and hTERT itself, suggesting a dual role for these proteins in
tumorigenesis and telomere maintenance.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2013.03.030.
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